1 domain / 2 areas / 2 specializations
Lumanity
Data updated
Global commercialization and market access advisory firm with published commentary on positioning psychedelic medicines within biopharmaceutical development frameworks.
Consultancy & Advisory Snapshot
Market Access & HEOR ConsultingGeography
Global
Coverage
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Monitoring-Only
Pipeline Stage Coverage
Client Types
Consultancy Notes
Lumanity is a life sciences consultancy with dual headquarters in Morristown, New Jersey and London, providing market access, HEOR, commercialisation, clinical and regulatory, and medical affairs services. Its documented psychedelic work is a December 2021 webinar, Psychedelic Medicines as Biopharmaceuticals: Not So Far Out, run by legacy unit Cello Health BioConsulting with panellists from Compass Pathways, Small Pharma, Bright Minds Biosciences and Beckley Psytech. No named psychedelic client engagements have been published since.
Documented Engagements
Industry webinar on psychedelic medicines as biopharmaceuticals
Dec 13, 2021
On-demand webinar moderated by Joel S. Sandler of the CNS practice, with executives from Compass Pathways, Small Pharma, Bright Minds Biosciences and Beckley Psytech.
Psychedelic Medicines as Biopharmaceuticals: Not So Far OutSource Evidence
Quick Facts
- Type
- Other
- Website
- Visit